• linkedin
  • Increase Font
  • Sharebar

    AUA 2016: Experts offer guidance on the meeting



    Prostate Cancer Markers/Surveillance

    Stacy Loeb, MDDr. LoebThe changing landscape of prostate cancer diagnosis and management continues to be a major theme, according to Stacy Loeb, MD, MSc.

    The 2012 U.S. Preventive Services Task Force recommendation against PSA-based prostate cancer screening and increasing use of active surveillance have led to a shift in the composition of patients undergoing radical prostatectomy, Dr. Loeb said.

    “Not surprisingly, active surveillance continues to be a hot topic at this year’s meeting. As more data continue to accrue showing the long-term safety of this management option, there are multiple studies looking into expanding the eligibility criteria. Look out for studies on expanding use of active surveillance in young men and using MRI-targeted biopsy to confirm eligibility,” said Dr. Loeb, assistant professor of urology and population health at New York University School of Medicine, New York.

    “There are also several studies on monitoring during active surveillance, including the utility of noninvasive biomarkers and multiparametric MRI,” she added.

    New biomarker findings will be another major theme at this year’s meeting.

    “Look out for new data on commercially available markers, as well as some new marker tests in the pipeline,” Dr. Loeb said.

    Dr. Loeb singled out the following abstracts from this year's meeting:


    PD08-01: Prediction of the cancer state to inform a personalized management program for prostate cancer
    Rebecca Coley


    PD08-07: Molecular Progression of Gleason 6 Prostate Cancer: Tracking of Specific Clones by Image-Guided Biopsy
    Ganesh Palapattu


    MP07-01: Validation of a genomic risk classifier to predict prostate cancer death in high risk patients
    R. Jeffrey Karnes


    MP07-12: Abdominal obesity, altered adipokynes and elevated C-peptide levels are associated with high Gleason score in patients undergoing diagnostic prostate biopsy: Data from prospective registry
    Jehonathan H Pinthus


    Dr. Loeb also highlighted these abstracts, from Prostate Cancer: Localized: Active Surveillance II:


    MP15-02: The Effect of Radical Prostatectomy, External Beam Radiation Therapy, and Active Surveillance on Life Insurance Premiums in Patients with Prostate Cancer
    Mark Biebel


    MP15-04: Variation in active surveillance follow-up over two years in diverse urology practices
    Amy Luckenbaugh MD


    MP15-15: A Retrospective Review of a Large Active Surveillance Cohort in Patients with Prostate Cancer at the Cleveland Clinic
    Yaw A. Nyame


    MP15-18: Multiparametric MRI outperforms PSA Velocity for Pathologic Progression in Men on Active Surveillance for Prostate Cancer
    Michael Kongnyuy

    Next: Localized PCa Treatment

    Benjamin P. Saylor
    Saylor is content managing editor for Urology Times.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available